Efficacy and Safety of Insulin Degludec/Insulin Aspart in Insulin-naïve Subjects With Type 2 Diabetes Using Two Dosing Regimens

NCT01365507 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

276

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2

Interventions

DRUG: insulin degludec/insulin aspart

Sponsor

Novo Nordisk A/S